Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

NCT00421980 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

NCT00418548 ·Status: COMPLETED ·Phase: PHASE3

Etanercept (Enbrel) in Ankylosing Spondylitis

NCT01289743 ·Status: UNKNOWN ·Phase: PHASE2

Extension Study Evaluating Etanercept in Ankylosing Spondylitis

NCT00410046 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain

NCT00873730 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

NCT00444340 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

NCT00434044 ·Status: COMPLETED ·Phase: PHASE3

Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.

NCT01421303 ·Status: COMPLETED

Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)

NCT00844142 ·Status: UNKNOWN ·Phase: PHASE2

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

NCT01258738 ·Status: COMPLETED ·Phase: PHASE3

Study Investigating Enbrel Treatment for Ankylosing Spondylitis

NCT00195416 ·Status: COMPLETED

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

NCT04507763 ·Status: COMPLETED

Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

NCT00273858 ·Status: TERMINATED

Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis

NCT02638896 ·Status: UNKNOWN ·Phase: PHASE4

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

NCT02486302 ·Status: COMPLETED

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

NCT01411215 ·Status: TERMINATED

Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis

NCT00247962 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis

NCT01298531 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

NCT00244556 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

NCT00245934 ·Status: COMPLETED

Etanercept (Enbrel) in Undifferentiated Spondyloarthritis

NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2

Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy

NCT00420303 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

NCT00503503 ·Status: COMPLETED

Defining Remission With Etanercept in AS in Real Life Clinical Practice

NCT02202850 ·Status: COMPLETED

Study Evaluating the Safety of Enbrel (Etanercept)

NCT00683384 ·Status: COMPLETED